Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.

Ítems similars

• Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy.
  per: Ruhnke, M, et al.
  Publicat: (1996)
• Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype.
  per: Millon, L, et al.
  Publicat: (1994)
• Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus.
  per: He, X, et al.
  Publicat: (1994)
• Replacement of Candida albicans with C. dubliniensis in Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis Treated with Fluconazole
  per: Martinez, Marcos, et al.
  Publicat: (2002)
• In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.
  per: Ruhnke, M, et al.
  Publicat: (1997)